Novartis (ADR) (NVS)
Develops innovative medicines across four therapeutic areas and multiple advanced technology platforms.
$141.28
After hours+0.01 (+0.01%)
At close$141.27(+0.21%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 7.14% | 136.17M ADS | |
|---|---|---|---|
| 1,672 holders · as of Jun 30, 2026 | |||
| Strategic holders | 7.32% | 139.60M ADS | |
| 1 holder · as of Jul 17, 2025 | |||
| Other | 85.54% | 1.63B ADS | |
| remainder | |||
1.91B ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
1,672 holders · 136.17M shares · 138 new positions · 670 increased · 583 reduced · 108 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Fisher Asset Management, LLC | 15.52M | 0.81% | +1.64M | Aug 4, 2026 |
| Morgan Stanley | 8.73M | 0.46% | +199.8K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 8.12M | 0.43% | +7.5K | Aug 11, 2026 |
| Primecap Management Co/CA/ | 6.59M | 0.35% | −975.2K | Aug 14, 2026 |
| Loomis Sayles & Co L P | 5.24M | 0.27% | −186.8K | Aug 14, 2026 |
| Bank of America Corp /DE/ | 4.91M | 0.26% | −52.9K | Aug 14, 2026 |
| Franklin Resources Inc | 3.25M | 0.17% | −158.7K | Aug 13, 2026 |
| BlackRock, Inc. | 3.05M | 0.16% | +98.2K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6.40% | 139.60M | 13G | Jul 17, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.